Differential diagnosis of classical Bartter syndrome and Gitelman syndrome: Do we need genetic analysis?

Amaç & Hipotez:Objective: Classical Bartter syndrome (cBS) and Gitelman syndrome (GS) are genotypically distinct, but there is a phenotypic overlapamong these two diseases, which can complicate the accurate diagnosis without genetic analysis.

📊

Temel Bulgular & Veri:This study aimed to evaluate thecorrelation between clinical and genetic diagnoses among patients who have genetically defined cBS and GS.Patients and Methods: The study included 18 patients with homozygous/compound heterozygous CLCNKB (NM_000085) (n:10/18)and SLC12A3 (NM_000339) (n:8/18) mutations.

💡

Sonuç & Katkı:We suggest to perform a genotypic classification ifgenetic analysis is possible.

🔬Tür:Araştırma Makalesi

📍Kapsam:Genişletilmiş Akademik Örneklem

⚙️Değişkenler:Bartter syndrome · Gitelman syndrome · Kidney tubuler disease

Abstract

Objective: Classical Bartter syndrome (cBS) and Gitelman syndrome (GS) are genotypically distinct, but there is a phenotypic overlapamong these two diseases, which can complicate the accurate diagnosis without genetic analysis. This study aimed to evaluate thecorrelation between clinical and genetic diagnoses among patients who have genetically defined cBS and GS.Patients and Methods: The study included 18 patients with homozygous/compound heterozygous CLCNKB (NM_000085) (n:10/18)and SLC12A3 (NM_000339) (n:8/18) mutations. Biochemical, clinical and radiological data were collected at presentation and at thelast visit.Results: In cBS group age at diagnosis, median plasma potassium and chloride concentrations were significantly lower and medianplasma HCO3 and blood pH values were significantly higher. Patients with GS had significantly lower median plasma magnesiumconcentrations and urinary calcium/creatinine ratio. One child with GS had normocalciuria, two children with cBS had hypocalciuriaand hypomagnesemia. Low estimated glomerular filtration rate (eGFR) (ml/dk/1.73m2) and growth failure were more evident in cBSgroup. In patients with cBS, nine different CLCNKB gene mutations were detected, five of them were novel. Novel mutations were:one nonsense (c.66G>A, p.Trp22*), one missense (c.499G>A, p.Gly167Ser) and three splice-site (c.867-2delA; c.499-2insG; c.1930-2A>C) mutations. In patients with GS, six different SLC12A3 gene mutations were found.Conclusions: It may not always be possible to clinically distinguish cBS from GS. We suggest to perform a genotypic classification ifgenetic analysis is possible.

Anahtar kelimeler

Bartter syndrome Gitelman syndrome Kidney tubuler disease Hypokalemic metabolic alkalosis

🔖

Bu Makaleye Atıf Yap

GUVEN, S., GOKCE, I., ALAVANDA, C., CICEK, N., DEMIRCI, E. B., SAK, M., PUL, S., TURKKAN, O. N., YILDIZ, N., ATA, P., ALPAY, H. (2021). Differential diagnosis of classical Bartter syndrome and Gitelman syndrome: Do we need genetic analysis?. Marmara Medical Journal, Cilt: 34 - Sayı: 3, 254–259. https://ajindex.com/articles/688291

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (8)

Besouw MTP, Kleta R, Bockenhauer D. Bartter and Gitelman syndromes: Questions of class. Pediatr Nephrol 2020;35:1815- 24.
Seyberth HW. Pathophysiology and clinical presentations of salt-losing tubulopathies. Pediatr Nephrol 2016; 31:407-18
Simon DB, Nelson-Williams C, Bia MJ. et al. Gitelman’s variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 1996; 12: 24-30. https://doi. org/10.1038/ng0196-24 [4] Kamel KS, Harvey E, Douek K, Parmar MS, Halperin ML. Studies on the pathogenesis of hypokalemia in Gitelman’s syndrome: Role of bicarbonaturia and hypomagnesemia. Am J Nephrol 1998;18:42-9
Ring T, Knoers N, Oh MS, Halperin ML. Reevaluation of the criteria for the clinical diagnosis of Gitelman syndrome. Pediatr Nephrol 2002;17:612-16.
Simon DB, Bindra RS, Mansfield TA. et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter’s syndrome type III. Nat Genet 1997;17:171-8
Messa HL, de Oliveira Achili Ferreira JC, Andreia Rangel- Santos, Vaisbich MH. Genetic spectrum of Brazilian suspected Bartter Syndrome Patients. https://doi.org/10.21203/ rs.3.rs-35560/v1(preprint
Sahbani D, Strumbo B, Tedeschi S, et al. Functional study of novel Bartter’s Syndrome mutations in ClC-Kb and rescue by the accessory subunit Barttin toward personalized medicine. Front Pharmacol 2020;11:327. https://doi.org/10.3389/ fphar.2020.00327 [9] Coto E, Rodriguez J, Jeck N, et al. A new mutation (intron 9 +1 G>T) in the SLC12A3 gene is linked to Gitelman syndrome in Gypsies. Kidney Int 2004;65:25-9. https://doi.org/10.1111/ j.1523-1755.2004.00388.x [10] Mastroianni N, Bettinelli A, Bianchetti M, et al. Novel molecular variants of the Na-Cl cotransporter gene are responsible for Gitelman syndrome. Am J Hum Genet 1996;59:1019-26. http://www.ncbi.nlm.nih.gov/pmc/articles/ pmc1914834 [11] Syrén ML, Tedeschi S, Cesareo L, et al. Identification of fifteen novel mutations in the SLC12A3 gene encoding the Na-Cl Cotransporter in Italian patients with Gitelman syndrome. Hum Mutat 2002;20:78. doi: 10.1002/humu.9045. Erratum in: Hum Mutat 2002;20:321
Colussi G, Bettinelli A, Tedeschi S, et al. A thiazide test for the diagnosis of kidney tubular hypokalemic disorders. Clin J Am Soc Nephrol 2007;2:454-60. https: